CMMB
Chemomab TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
CMMB vs peer average
45/100
CMMB vs. peer average (F vs. F)
Grade spread
D 3 · F 7
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AKTX is the first available peer comparator.
Same-sector microcap benchmark; the packet provides no direct PSC or nebokitug read-through, so comparison is mainly volatility and financing risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CMMB
Chemomab Therapeutics
AKTX
Akari Therapeutics
Grade
F
F
Momentum
84
40
Value
41
42
Sentiment
10
17
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AKTX
CMMB / AKTX
Grade Position
In line
CMMB vs. peer average (F vs. F)
45/100
Momentum
84
CMMBValue
41
AKTXSentiment
10
AKTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CMMB
AKTX is the first peer returned for this comparison set.

